What are the benefits of using PT-141 peptide therapy?

Research-grade PT-141 isn’t a peptide therapy, so it has no established benefits for anyone. The benefit data that exist come from the approved drug, Vyleesi. In two 24-week phase 3 trials of 1,247 premenopausal women with hypoactive sexual desire disorder, bremelanotide produced modest gains in desire scores and less distress than placebo, but no difference in satisfying sexual events. The label notes that it doesn’t enhance sexual performance.

The label also lists nausea in about 40% of trial participants and a temporary rise in blood pressure. Claims for men or postmenopausal women rest on small or early studies. In the lab, PT-141 is a tool for studying melanocortin signaling. Read our research purposes only policy, then buy PT 141 Peptide online.

PT-141 10MG
PT-141 10MG